HST Global Inc. Operating Income Growth

Operating Income Growth of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending June 29, 2020 was -25.86% (a -726.15% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth decreased by -56.14%
  • Annual Operating Income Growth for 2019 was -6.31% (a -192.79% decrease from previous year)
  • Annual Operating Income Growth for 2018 was 6.8% (a -159.49% decrease from previous year)
  • Annual Operating Income Growth for 2017 was -11.43% (a -180.55% decrease from previous year)
  • Twelve month Operating Income Growth ending June 29, 2020 was -13.4% (a 107.75% increase compared to previous quarter)
  • Twelve month trailing Operating Income Growth increased by 3.63% year-over-year
Trailing Operating Income Growth for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-13.4% -6.45% -6.31% -12.93%
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of HST Global Inc.

Most recent Operating Income Growthof HSTC including historical data for past 10 years.

Interactive Chart of Operating Income Growth of HST Global Inc.

HST Global Inc. Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -25.86% 4.13%
2019 26.3% -58.96% 1.97% 4.22% -6.31%
2018 -0.87% -11.25% -2.6% 28.49% 6.8%
2017 0.87% 7.16% 3.08% -58.21% -11.43%
2016 11.05% -3.08% 1.38% 36.07% 14.19%
2015 -10.2% 14.02% 5.73% -40.11% -7.38%
2014 -5.69% -1.89% 31.06% -19.87% 5.28%
2013 58.87% 55.3% 44.74% 59.59% 54.03%
2012 67.52% -1.22% -1.82% 9.81% 32.13%
2011 -212.5% 45.33% 68.06% 59.24% 32.95%
2010 87.81% 51.61% 11.43% 42.86%

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.